These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9836374)

  • 21. The role of cytokines and growth factors in cartilage destruction in osteoarthritis and rheumatoid arthritis.
    van den Berg WB
    Z Rheumatol; 1999 Jun; 58(3):136-41. PubMed ID: 10441840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4.
    van Roon JA; van Roy JL; Gmelig-Meyling FH; Lafeber FP; Bijlsma JW
    Arthritis Rheum; 1996 May; 39(5):829-35. PubMed ID: 8639180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis.
    Korb-Pap A; Stratis A; Mühlenberg K; Niederreiter B; Hayer S; Echtermeyer F; Stange R; Zwerina J; Pap T; Pavenstädt H; Schett G; Smolen JS; Redlich K
    Ann Rheum Dis; 2012 Jun; 71(6):1004-11. PubMed ID: 22258493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
    Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
    J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arguments for interleukin 1 as a target in chronic arthritis.
    van den Berg WB
    Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i81-4. PubMed ID: 11053095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis.
    Chabaud M; Lubberts E; Joosten L; van Den Berg W; Miossec P
    Arthritis Res; 2001; 3(3):168-77. PubMed ID: 11299057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage.
    Hardingham TE; Bayliss MT; Rayan V; Noble DP
    Br J Rheumatol; 1992; 31 Suppl 1():1-6. PubMed ID: 1532522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of TNF alpha in the induction of antigen induced arthritis in the rabbit and the anti-arthritic effect of species specific TNF alpha neutralising monoclonal antibodies.
    Lewthwaite J; Blake S; Hardingham T; Foulkes R; Stephens S; Chaplin L; Emtage S; Catterall C; Short S; Nesbitt A
    Ann Rheum Dis; 1995 May; 54(5):366-74. PubMed ID: 7794042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
    Abramson SB; Amin A
    Rheumatology (Oxford); 2002 Sep; 41(9):972-80. PubMed ID: 12209029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction.
    Joosten LA; Lubberts E; Durez P; Helsen MM; Jacobs MJ; Goldman M; van den Berg WB
    Arthritis Rheum; 1997 Feb; 40(2):249-60. PubMed ID: 9041936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local interleukin-1-driven joint pathology is dependent on toll-like receptor 4 activation.
    Abdollahi-Roodsaz S; Joosten LA; Koenders MI; van den Brand BT; van de Loo FA; van den Berg WB
    Am J Pathol; 2009 Nov; 175(5):2004-13. PubMed ID: 19834062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra.
    Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
    Arthritis Rheum; 1996 May; 39(5):797-809. PubMed ID: 8639177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TNF-induced structural joint damage is mediated by IL-1.
    Zwerina J; Redlich K; Polzer K; Joosten L; Krönke G; Distler J; Hess A; Pundt N; Pap T; Hoffmann O; Gasser J; Scheinecker C; Smolen JS; van den Berg W; Schett G
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11742-7. PubMed ID: 17609389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of TNF-alpha in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera.
    Matsuno H; Yudoh K; Katayama R; Nakazawa F; Uzuki M; Sawai T; Yonezawa T; Saeki Y; Panayi GS; Pitzalis C; Kimura T
    Rheumatology (Oxford); 2002 Mar; 41(3):329-37. PubMed ID: 11934972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium.
    Harigai M; Hara M; Yoshimura T; Leonard EJ; Inoue K; Kashiwazaki S
    Clin Immunol Immunopathol; 1993 Oct; 69(1):83-91. PubMed ID: 8403545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88.
    Joosten LA; Koenders MI; Smeets RL; Heuvelmans-Jacobs M; Helsen MM; Takeda K; Akira S; Lubberts E; van de Loo FA; van den Berg WB
    J Immunol; 2003 Dec; 171(11):6145-53. PubMed ID: 14634130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis.
    Li X; Yuan FL; Lu WG; Zhao YQ; Li CW; Li JP; Xu RS
    Biochem Biophys Res Commun; 2010 Jun; 397(2):131-5. PubMed ID: 20513356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators.
    van de Loo FA; van den Berg WB
    Rheum Dis Clin North Am; 2002 Feb; 28(1):127-49. PubMed ID: 11840694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.